Skip to main content

You are here

Lung Cancer

Lung Cancer

Lung Cancer

If you have been NEWLY DIAGNOSED START HERE

Disease Learning

Video Library

Case Based Panel Discussion - Choosing Between Targeted Therapy and Immunotherapy in a Patient with an EGFR Mutation and High PDL-1 Expression

Drs Zofia Piotrowska, H. Jack West, and Taofeek Owonikoko sit down to discuss a series of case-based scenarios. In this video, the doctors discuss the treatment choice between targeted therapy and immunotherapy in a patient with an EGFR Mutation and high PDL-1.

Cancer Journey:

Just Diagnosed, In Treatment

Cancer Type:

Disease Learning:

Targeted Therapy, General Lung Cancer, Non Small Cell Lung Cancer, Immunotherapies

Case Based Panel Discussion - Metastatic Squamous NSCLC Low Tumor PD-L1 Frail Patient - Treatment?

Drs Zofia Piotrowska, H. Jack West, and Taofeek Owonikoko sit down to discuss a series of case-based scenarios. In this video, the doctors discuss a frail patient with metastatic squamous NSCLC with low tumor PD-L1 expression, and the best treatment approach for this patient.

Cancer Journey:

Just Diagnosed, In Treatment

Cancer Type:

Disease Learning:

Aging and Elderly, General Lung Cancer, Non Small Cell Lung Cancer, Tumor Marker Tests, Immunotherapies, Chemotherapy

Case Based Panel Discussion - Rapid Progression Adenocarcinoma High PD-L1 - How Do You Treat?

Drs Zofia Piotrowska, H. Jack West, and Taofeek Owonikoko sit down to discuss a series of case-based scenarios. In this video, the doctors discuss treating a patient with rapidly progressing lung adenocarcinoma and high tumor PD-L1 expression.

Cancer Journey:

Cancer Type:

Disease Learning:

Non Small Cell Lung Cancer, Tumor Marker Tests

,

,

,

,

Molecular Diagnostics Testing and Next Generation Sequencing

The Global Resource for Advancing Cancer Education (GRACE), presents Molecular Diagnostic Testing and Next Generation Sequencing in Lung Cancer webinar series.

Cancer Journey:

Just Diagnosed, In Treatment

Cancer Type:

Disease Learning:

General Lung Cancer, Molecular Testing

,

,

,

,

2017 Advances in Immunotherapy: What Lung Cancer Patients Need to Know OncTalk

The Global Resource for Advancing Cancer Education (GRACE), in partnership with Georgetown University Hospital is pleased to present the videos from the panel discussion "2017 Advances in Immunotherapy: What Lung Cancer Patients Need to Know".

Cancer Journey:

Just Diagnosed, In Treatment

Cancer Type:

Disease Learning:

Biopsy/Tissue Collection, Tumor Marker Tests, Targeted Therapy, First-line treatment, Clinical Trials, Investigational Agents, Immunotherapies, Second-line treatment

Articles

My Top 10 ASCO 2017 Lung Cancer Presentations

Over the next few days, about 30,000 oncologists and other cancer care professionals, along with a growing number of patient advocates, are...

Cancer Journey:

Just Diagnosed, In Treatment

Cancer Type:

Disease Learning:

Non Small Cell Lung Cancer, Small Cell Lung Cancer

New FDA Approval for Zykadia (ceritinib) for ALK-Positive NSCLC: Why I Think It's a Poor Choice for Initial Treatment

The FDA just approved a new therapy for the approximately 4% of patients with NSCLC who have the molecular marker known as an ALK rearrangement. The...

Cancer Journey:

In Treatment, Just Diagnosed

Cancer Type:

Disease Learning:

Targeted Therapy

Targeted Therapies Patient Forum September 2017 Speaker Highlight - James Stevenson, MD

GRACE is excited to continue to build the faculty and agenda for the upcoming Targeted Therapies Patient Forum, September 16, 2017. See more information about our presenters in Speaker Highlights - today we introduce James Stevenson, MD.

Cancer Journey:

Cancer Type:

Disease Learning:

Targeted Therapy

Translation of Molecular Genetics in Lung Cancer into Treatment Decision

Christine M. Walko, Pharm.D., discusses how advancements in technology have improved the quality, cost and turnaround time for assessing genetic mutations in tumor tissue, and how this has helped to translate precision medicine into standard clinical practice.

Cancer Journey:

In Treatment, Just Diagnosed

Cancer Type:

Disease Learning:

General Lung Cancer

Imprecision Medicine: Why Keytruda (Pembrolizumab) + Chemo for PD-L1+ NSCLC isn't Ready for Prime Time

Let me start by saying that I'm a fan of the immune checkpoint inhibitor Keytruda (pembrolizumab) and consider it the new standard of care as a...

Cancer Journey:

Just Diagnosed, In Treatment

Cancer Type:

Disease Learning:

First-line treatment, Targeted Therapy, Chemotherapy

Community Forum

Mother-in-Law was diagnosed with NSCLC and after a blood biopsy, doctor is recommending Osimertinib. I tried searching on the main page, but it wasn'...

Cancer Journey:

Cancer Type:

Disease Learning:

Lung Cancer, Drugs, Targeted Therapies - EGFR, First-line treatment, Non Small Cell Lung Cancer

Berberine and Tarceva

Wondering if anyone has info on compatibility of berberine with Tarceva. I called Genentech but they didn’t know. I am taking it because it has...

Cancer Journey:

Cancer Type:

Disease Learning:

Well, here we are, barring any last minute complications my wife should start the TAK-788 trial next week. She has already had her main blood work...

Cancer Journey:

Cancer Type:

Disease Learning:

Silibinin effective for brain metastases in lung cancer

This seems to be an option for everyone with brain metastases (inform your doctor as it is quite new) ) Here are links to research done in Spain in...

Cancer Journey:

Cancer Type:

Disease Learning:

Lung Cancer, General Lung Cancer, Radiation Therapy, Non Small Cell Lung Cancer

Osimertinib best after Afatinib ? (with no result from liquid biopsies)

My mum (73years,IVstage,small meta in lymph nodes,EGFR+,exon18,G719X), was for 21 months on 1st line Afatinib (first 40% reduction, last three months...

Cancer Journey:

Cancer Type:

Disease Learning:

Lung Cancer, General Lung Cancer, Targeted Therapies - EGFR, Non Small Cell Lung Cancer